|
|
| Quarterly Results |
|
| Syngene International Ltd | | Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln | Chairman : Kiran Mazumdar Shaw | | Home : Indian Private | Book Value: 104.1404189 | | BSE Code : 539268 | Market Cap: 28107.14 | | NSE Code : SYNGENE | P / E : 59.07 | |
| |
|
|
|
|
|
|
| (Rs in Cr.) |
|
|
| Type | 4Qtr | 3Qtr | 2Qtr | 1Qtr | | Net Sales | 864.70 | 791.90 | 830.70 | 715.80 | | Other Income | 15.30 | 28.80 | 21.00 | 22.90 | | Total Income | 880.00 | 820.70 | 851.70 | 738.70 | | Total Expenditure | 565.40 | 596.10 | 621.50 | 552.40 | | Operating Profit | 314.60 | 224.60 | 230.20 | 186.30 | | Interest | 8.50 | 6.30 | 8.60 | 6.10 | | Gross Profit | 306.10 | 218.30 | 221.60 | 180.20 | | Depreciation | 95.70 | 93.60 | 90.90 | 88.70 | | Tax | 41.50 | 19.10 | 22.80 | 16.40 | | Deferred Tax | -20.90 | 5.80 | 6.30 | -0.20 | | Reported Profit After Tax | 189.80 | 99.80 | 101.60 | 75.30 |
|
|
|
|
|